Why Premier Biotech’s NexScreen and TransMed acquisitions could reshape rapid drug testing
Discover how Premier Biotech’s NexScreen and TransMed acquisitions expand point-of-care testing, e-commerce and global diagnostics reach.
Discover how Premier Biotech’s NexScreen and TransMed acquisitions expand point-of-care testing, e-commerce and global diagnostics reach.
CorVista Health presents machine-learned non-invasive INOCA detection data at ACC.26. Analysis of what this means for cardiology and women's heart care. Read more.
Find out how Henry Schein’s exclusive U.S. deal for CytoChip’s CLIA-waived CitoCBC could reshape point-of-care blood diagnostics.
Find out why PathoCare's $1.75B valuation and expanded $50M financing round could signal a breakthrough moment for AI-powered point-of-care diagnostics.